摘要
目的:探讨Survivin siRNA对肺癌A549细胞吉西他滨化疗敏感性的影响。方法:肺癌A549细胞分为siRNA转染组、吉西他滨组、siRNA转染+吉西他滨组和正常对照组;噻唑蓝比色法(MTT法)检测各组细胞增殖率的变化,流式细胞仪分析各组细胞的细胞周期和存活率。结果:Survivin siRNA+吉西他滨组细胞的增殖率和存活率均明显低于siRNA转染组和吉西他滨组(P<0.01);且siRNA+吉西他滨组与siRNA转染组、吉西他滨组比较,更高比率的A549细胞被阻滞于S期(P<0.01)。结论:siRNA沉默Survivin表达,增加了肺癌A549细胞对吉西他滨的化疗敏感性。
Objective:To investigate the effects of Survivin siRNA on chemosensitivity of lung cancer cells A549 to gemcitabine in vitro.Methods:Lung cancer ceils A549 were divided into 4 groups:Survivin siRNA group, gemcitabine group, Survivin siRNA + gemcitabine group and normal control group.The effects of Survivin siRNA and gemcitabine on cell proliferation, cell cycle and cell survival were analyzed by MTT assay and flow cytometry respectively.Results:The proliferation rate and survival rate of cells in Survivin siRNA + gemcitabine group were obviously lower than that in Survivin siRNA group and gemcitabine group (P 〈 0.01). Moreover, compared with Survivin siRNA group and gemcitabine group, more A549 cells in Survivin siRNA + gemcit^bine group were blocked in S stage (P 〈 0.01).Conelusions:Silenting the Survivin gene expression by siRNA can increase the chemosensitivity of lung cancer cells A549 to gemcitabine.
出处
《承德医学院学报》
2010年第1期3-5,共3页
Journal of Chengde Medical University